Get the Stockscreener App
45.01
0.79%
-0.35
After Hours:
45.05
0.04
+0.09%
Artivion Inc stock is traded at $45.01, with a volume of 208.75K.
It is down -0.79% in the last 24 hours and up +0.92% over the past month.
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.
See More
Previous Close:
$45.36
Open:
$45.4
24h Volume:
208.75K
Relative Volume:
0.60
Market Cap:
$2.13B
Revenue:
$405.04M
Net Income/Loss:
$-17.90M
P/E Ratio:
-104.75
EPS:
-0.4297
Net Cash Flow:
$7.66M
1W Performance:
-1.34%
1M Performance:
+0.92%
6M Performance:
+48.56%
1Y Performance:
+54.06%
1-Day Range:
$44.11
$45.48
1-Week Range:
$43.70
$46.84
52-Week Range:
$21.97
$48.25
Artivion Inc Stock (AORT) Company Profile
Name
Artivion Inc
Sector
Industry
Phone
(770) 419-3355
Address
1655 ROBERTS BOULEVARD N W, KENNESAW
Compare AORT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AORT
Artivion Inc
|
45.03 | 2.15B | 405.04M | -17.90M | 7.66M | -0.4297 |
|
ABT
Abbott Laboratories
|
127.03 | 222.19B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
98.67 | 144.97B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
367.58 | 140.12B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
99.76 | 128.60B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
84.85 | 49.82B | 5.88B | 1.34B | 799.60M | 2.3489 |
Artivion Inc Stock (AORT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-13-25 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| Jun-17-25 | Initiated | Canaccord Genuity | Buy |
| Oct-23-24 | Initiated | JMP Securities | Mkt Outperform |
| Sep-27-22 | Reiterated | Lake Street | Buy |
| Aug-08-22 | Initiated | Lake Street | Buy |
| Mar-03-22 | Initiated | Stifel | Buy |
View All
Artivion Inc Stock (AORT) Latest News
Fundamentals Check: Why Artivion Inc CYL stock benefits from AI revolution2025 Price Targets & Low Risk High Reward Trade Ideas - moha.gov.vn
Aug Sectors: Why Artivion Inc stock could be next leaderWeekly Profit Analysis & Verified Technical Signals - moha.gov.vn
Will Artivion Inc. stock recover faster than marketHigh Beta Stocks & Exceptional Growth Portfolio - bollywoodhelpline.com
3 Reasons to Sell AORT and 1 Stock to Buy Instead - Finviz
Momentum Shift: How Artivion Inc stock performs during Fed tightening cycles2025 Short Interest & Detailed Earnings Play Alerts - moha.gov.vn
Published on: 2026-01-04 17:22:06 - earlytimes.in
Artivion Continues Building Toward Bigger And Better Things (NYSE:AORT) - Seeking Alpha
Short Squeeze: How Artivion Inc CYL stock performs in easing cycles2025 Trading Volume Trends & Intraday High Probability Setup Alerts - moha.gov.vn
Squarepoint Ops LLC Takes $664,000 Position in Artivion, Inc. $AORT - MarketBeat
Is Artivion Inc. stock a bargain at current levels2025 Technical Patterns & Expert Verified Movement Alerts - Улправда
Wall Street Zen Upgrades Artivion (NYSE:AORT) to Strong-Buy - MarketBeat
Can Artivion Inc. stock sustain revenue momentumJuly 2025 Short Interest & High Yield Stock Recommendations - Улправда
Is Artivion Inc. stock a buy in volatile marketsJuly 2025 Trends & Free Community Supported Trade Ideas - Улправда
Assessing Artivion (AORT) Valuation After Analyst Upgrades and New On-X Valve Clinical Data - Sahm
Will Artivion Inc. stock benefit from commodity pricesFed Meeting & Weekly Top Performers Watchlists - Улправда
Nihon Kohden (OTCMKTS:NHNKY) and Artivion (NYSE:AORT) Financial Contrast - Defense World
Is Artivion Inc. stock a safe buy before earnings2025 Technical Patterns & Verified Swing Trading Watchlist - Улправда
Aug Highlights: Can Artivion Inc. (CYL) stock resist broad market declines2025 Market Sentiment & Weekly High Momentum Picks - DonanımHaber
Why Artivion Inc. stock could rally in 2025Trade Risk Assessment & Reliable Entry Point Alerts - Улправда
Will Artivion Inc. stock pay special dividends2025 Institutional Moves & Verified Entry Point Detection - DonanımHaber
Can Artivion Inc. (CYL) stock resist broad market declinesWeekly Trade Review & Advanced Technical Analysis Signals - DonanımHaber
Is Artivion Inc. stock a good choice for value investorsEarnings Growth Summary & Technical Buy Zone Confirmation - DonanımHaber
Analyst Calls: Will Artivion Inc. stock benefit from commodity pricesJuly 2025 Opening Moves & Verified Swing Trading Watchlists - Улправда
Artivion, Inc. (NYSE:AORT) Given Consensus Rating of “Moderate Buy” by Analysts - Defense World
Artivion, Inc. (NYSE:AORT) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
Insider Sell: John Davis Sells 5,000 Shares of Artivion Inc (AOR - GuruFocus
Artivion (AORT) Stock Up on Analyst Buy Rating and Positive Clinical DataNews and Statistics - IndexBox
Artivion (NYSE:AORT) Hits New 1-Year HighStill a Buy? - MarketBeat
Artivion (AORT) Stock Is Up, What You Need To Know - Finviz
Artivion, Inc. (AORT) insider sale: CCO sells 5,000 shares at $45.11 per share - Stock Titan
ARTIVION's Chief Commercial Officer Sells 5,000 Shares - TradingView — Track All Markets
VP Davis Sells 5,000 ($225.6K) Of Artivion Inc [AORT] - TradingView — Track All Markets
Artivion Inc stock hits all-time high at 48.06 USD By Investing.com - Investing.com South Africa
Artivion Inc stock hits all-time high at 48.06 USD - Investing.com India
[144] ARTIVION, INC. SEC Filing - Stock Titan
Canaccord Genuity reaffirms Buy rating on Artivion stock at $51 target By Investing.com - Investing.com South Africa
Canaccord Genuity reaffirms Buy rating on Artivion stock at $51 target - Investing.com Nigeria
We Think Artivion (NYSE:AORT) Is Taking Some Risk With Its Debt - 富途牛牛
How the Narrative Around Artivion Is Evolving After Strong Growth and Mixed Analyst Views - Yahoo Finance
Artivion (NYSE:AORT) Cut to "Buy" at Wall Street Zen - MarketBeat
Osterweis Capital Management Inc. Acquires New Shares in Artivion, Inc. $AORT - MarketBeat
Ophir Asset Management Pty Ltd Sells 380,242 Shares of Artivion, Inc. $AORT - MarketBeat
Insider Selling: Artivion (NYSE:AORT) CAO Sells 4,572 Shares of Stock - MarketBeat
Artivion (AORT) VP & CAO sells 4,572 shares in RSU tax withholding - Stock Titan
AORT (AORT) investor plans Rule 144 sale of 4,572 shares on NYSE - Stock Titan
Russell Investments Group Ltd. Sells 68,082 Shares of Artivion, Inc. $AORT - MarketBeat
Artivion Inc Stock (AORT) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.20%
0.21%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):